Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2009. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of insider share transactions and does not contain financial performance data.
Material Changes
The filing details share acquisitions by Mr. S A Hussain under the Company's Share Reward Plan. Transactions occurred on four dates in late 2008:
- September 9, 2008: Acquisition of 9 shares (personal) and 9 shares (company match) at £12.72 per share.
- October 9, 2008: Acquisition of 12 shares (personal) and 12 shares (company match) at £11.20 per share.
- November 11, 2008: Acquisition of 10 shares (personal) and 10 shares (company match) at £12.15 per share.
- December 9, 2008: Acquisition of 10 shares (personal) and 10 shares (company match) at £12.30 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share purchases in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the total number of shares acquired by Mr. S A Hussain (50 personal shares and 50 matched shares).
- Confirm the share price fluctuations during the transaction dates (ranging from £11.20 to £12.72).
- Note that this filing does not impact the company's financial statements directly but reflects executive participation in the Share Reward Plan.